FDA Adverse Event Reporting Reg Offers Few Exceptions
This article was originally published in The Pink Sheet Daily
Companies must submit post-market safety reports electronically beginning in June 2015; waivers will be allowed, but they would only be temporary.
You may also be interested in...
Because some submitters will not have enough time to register for new electronic submission system, FDA will continue accepting paper post-marketing safety reports a little longer.
Generic drug labeling, drug shortages and compounding will be tackled in regulations in 2015; three documents weave together a picture of FDA’s upcoming actions on pharmaceutical-related rules.
FDA draft guidance explains procedures sponsors should use for electronic submissions to the Vaccine Adverse Event Reporting System when new requirements take effect in June 2015.